BeyondSpring

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$1.05-$4
Market Cap
$68.9M
Shares Short
1M

Financials

See more
Revenue (12 Mos)
$1.8M
Revenue Growth (YoY)
14.3%
Gross Profit (12 Mos)
$1.3M
Diluted EPS
-$0.40

News

See more

Yahoo Finance • 10 days ago

SEED Receives FDA Rare Pediatric Disease and Orphan Drug Designations for Lead Oncology Asset RBM39 Degrader and Enters Strategic Transactions with New Investors

Yahoo Finance • 10 days ago

BeyondSpring Announces $35.4 Million Sale of a Portion of Equity Interest in SEED Therapeutics to Advance Lead Asset Plinabulin to Anti-Cancer Registrational Studies

Yahoo Finance • last year

BeyondSpring Presents Poster Highlighting Preclinical and Clinical POC Immunomodulating Activity of Plinabulin Inducing Dendritic Cell Maturation and Re-sensitization in Immunotherapy Refractory Tumors when Combined with Radiation and PD-1/PD-L1 Inhibitors

Yahoo Finance • last year

BeyondSpring Regains Compliance with Nasdaq Minimum Bid Price Requirement

About

CEO
Dr. Lan Huang Ph.D.
Address
100 Campus Drive, Florham Park, NJ, United States, 07932
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
36